The Partnership for Safe Medicines (PSM) strongly believes that that no one should be able to purchase prescription drugs, including controlled substances, over the Internet without a valid prescription and physician oversight. Last year we sent every member of Congress a postcard that illustrated this face and earlier this year, my colleague Dr. Bryan Liang published a paper in the American Journal of Law & Medicine that highlights how Internet search engines support illegal online drug sales and identified three key ways we can stop “online pharmacies” from peddling their dangerous wares in cyberspace.
Read MoreThe U.S. Food and Drug Administration (FDA) and the McKinney, Texas, Police Department have reported that on August 7 a tractor-trailer truck containing a 35,760-carton shipment Dey brand generic Albuterol Sulfate Inhalation Solution was stolen in McKinney, Texas. We are concerned that they could make their way to consumers via online pharmacies.
Read MoreFive Capital Region doctors were convicted in federal court today on charges of misbranding drugs after they admitted to using a cheaper Botox substitue on unsuspecting patients, reports CBS News. The Plastic Surgery Group, LLP, of Albany(TPSG), pleaded guilty to the charge after an investigation found the doctors in the practice had been injecting patients…
Read MorePart 3: Implications for the U.S. and the Drug Importation Debate – As the debate surrounding the possible ban on the repackaging of medicines in Europe simmers to a boil, here in the United States the potentially dangerous practice of ordering prescription medicines via the Internet is mushrooming. Enticed by the promise of cheaper drugs and convenience by buying online, patients are largely unaware of the risks that come with online pharmacies. These risks can range from receiving products with too much, too little or no active ingredients, to being exposed to counterfeit products, which in some rare cases have been found to contain rat poison, boric acid and even inkjet cartridges!
Read MorePart 1: Your critical role in safe medicines — In recent blog entries, the Partnership for Safe Medicines’ (PSM) experts have warned consumers and pharmacists of the dangers that counterfeit drugs pose, recapped legislation surrounding these issues and highlighting incidents of counterfeit drugs from across the world. However, this month we have invited guest blogger Gregory Zec to share his thoughts on some current drug safety issues. This week, Gregory uses a fictional consumer’s experiences (which he based on real patients’ stories) to explore the confusion many patients encounter from when they receive repackaged, imported prescription drugs from a legitimate pharmacy.
Read MorePeriodically proposals are floated both in Washington, DC and state capitols that would allow Americans to import drugs from 32 “permitted” countries – Australia, Canada, Japan, New Zealand, Switzerland and the 27 members of the European Union. There is a perception that these countries have “safe” drug supplies insulated from the dangers that every other nation in the world.
Read MoreThe cost of counterfeiting is much more than money. In too many cases, counterfeiting costs human health and in some cases lives. For example, a group of clinics in Sierra Leone were closed last week for allegedly administering counterfeit drugs. Other cases involving online drug sellers have claimed the health and lives of patients who bought from illicit Web sites.
Read MoreIt’s happening all the time. Nearly every day, there are new reports of counterfeit drugs flooding the world’s prescription drug market. Just last week, the Partnership for Safe Medicines posted a link about how counterfeit drugs are hastening drug-resistant strains of malaria. And the week before, we shared the news reports out of the United Kingdom about a raid on an Irish counterfeit drug distribution operation and the MHRA’s recall due to possible counterfeit inhalers found in the U.K. supply system.
Read MoreOn May 5, the U.S. Food and Drug Administration (FDA) administered a warning against General Mills regarding the claim that Cheerios® Toasted Whole Grain Oat Cereal has the ability to lower cholesterol. Basically, the FDA cited General Mills for marketing Cheerios® as a cholesterol-reducing drug. I believe the FDA’s points are valid and factual, but I have to ask – Shouldn’t our agency watchdog be focusing greater attention on the operators of thousands of Web sites and
Read More